Castle Biosciences, Inc. - stock earnings
CSTL Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| July 31, 2024 BeforeMarket | - / - | 54.2 million | - / 67.1 million | 75.6 million |
CSTL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -2.5 million USD | 73.0 million USD |
| 2023Q4 | -2.6 million USD | 66.1 million USD |
| 2023Q3 | -6.9 million USD | 61.5 million USD |
| 2023Q2 | -18.8 million USD | 50.1 million USD |
| 2023Q1 | -29.2 million USD | 42.0 million USD |
| 2022Q4 | -20.6 million USD | 38.3 million USD |
| 2022Q3 | -18.8 million USD | 37.0 million USD |
| 2022Q2 | -1.6 million USD | 34.8 million USD |
| 2022Q1 | -24.6 million USD | 26.9 million USD |
| 2021Q4 | -6.4 million USD | 25.0 million USD |
| 2021Q3 | -11.8 million USD | 23.5 million USD |
| 2021Q2 | -8.8 million USD | 22.8 million USD |
| 2021Q1 | -4.3 million USD | 22.8 million USD |
| 2020Q4 | -4.9 million USD | 17.3 million USD |
| 2020Q3 | -4.6 million USD | 15.2 million USD |
| 2020Q2 | -1.4 million USD | 12.7 million USD |
| 2020Q1 | 570000 USD | 17.4 million USD |
| 2019Q4 | 2.1 million USD | 17.6 million USD |
| 2019Q3 | 5.8 million USD | 14.8 million USD |
| 2019Q2 | -1.3 million USD | 10.7 million USD |
| 2019Q1 | -1.4 million USD | 8.7 million USD |
| 2018Q4 | 3.9 million USD | 11.4 million USD |
| 2018Q3 | -3.5 million USD | 3.7 million USD |
| 2018Q2 | -3.2 million USD | 4.0 million USD |
| 2018Q1 | -3.6 million USD | 3.7 million USD |
CSTL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -57.5 million USD | 219.8 million USD |
| 2022 | -67.1 million USD | 137.0 million USD |
| 2021 | -31.3 million USD | 94.1 million USD |
| 2020 | -10.3 million USD | 62.6 million USD |
| 2019 | 5.3 million USD | 51.9 million USD |
| 2018 | -6.4 million USD | 22.8 million USD |
| 2017 | -12.4 million USD | 13.8 million USD |
CSTL
Price: $24.24
52 week price:
Earnings Per Share: -1.13 USD
P/E Ratio: -8.24
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 126500
Market Capitalization: 656.9 million